Egis is a member of Medicines for Europe. Consequently, it must comply with the provisions of the Transparency Rules Chapter of the Code of Conduct of Medicines for Europe, regulating the disclosure of engagements and transfers provided by the members for healthcare professionals, healthcare organisations and patient organisations, and the provisions of the Generic Transparency Code, which implements those transparency rules in Hungary. According to the Generic Transparency Code, Egis must document and disclose on its website all engagements and transfers which it provides, either directly or indirectly, to or with a view to a healthcare professional, healthcare organisation or a patient organisation. Further information: 

Disclosure of Supports/Sponsorships to Patient Organisations  (Code of Ethics for Pharmaceutical Marketing Communications) Further information:

Ethical standards to be followed by Egis

The amended Code of Ethics for Pharmaceutical Communications signed by the four Hungarian pharmaceutical manufacturers' association came into force on 1 July 2017. The aim of establishing the code was to ensure the highest level of protection of patients’ interests, and to ensure that the most stringent rules are in place for the pharmaceutical actors themselves. Further information:

Code of Ethics of the Servier Group: Ethical charter

Code of Conduct of the Servier Group:  Code of Conduct 

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox